The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Effect of Heparin and Heparin Fractions on Platelet Aggregation
Open accessAbstract
Porcine intestinal mucosal heparin induced aggregation of platelets in citrated platelet-rich plasma and enhanced platelet aggregation and serotonin secretion induced by other agents. This action of heparin was blocked by substances that elevate platelet cyclic AMP and by EDTA but not by inhibitors of platelet cyclooxygenase. The effect was not inhibited by apyrase or by N-amylthio-5'-AMP and therefore did not require the action of ADP, nor was there activation of platelet phospholipase. Platelet aggregation by heparin required a plasma cofactor different from the cofactor required for ristocetin. Fractionation of heparin yielded preparations that varied in molecular weight and, within a given molecular weight fraction, in affinity for antithrombin III. Fractions of high molecular weight (average 20,000) were more reactive with platelets than were fractions of low molecular weight (7,000). Anticoagulant activity did not parallel the platelet reactivity of heparin fractions. Among high molecular weight fractions, preparations of high or low antithrombin affinity were equally active in induction of platelet aggregation. In low molecular weight fractions, there was an inverse relationship between platelet reactivity and anticoagulant activity in normal platelet-rich plasma, but, in platelet-rich plasma depleted of antithrombin, low molecular weight fractions of high and low antithrombin affinity reacted equally with platelets. These results suggest that formation of an antithrombin-heparin complex protected platelets from aggregation by heparin. Selection of heparin fractions of low molecular weight and high antithrombin affinity may improve anticoagulant therapy and development of thromboresistant heparin-coated artificial materials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SNEDECOR, G. W. (1939) · Soil Science · doi:10.1097/00010694-193902000-00006 · Cited by 19,359
Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity
HUNTER, W. M., & GREENWOOD, F. C. (1962) · Nature · doi:10.1038/194495a0 · Cited by 6,919
Nonparametric Statistical Methods
(1999) · Technometrics · doi:10.1080/00401706.1999.10485954 · Cited by 6,090
Principles and procedures of statistics: McGraw-Hill Book Company, Inc. New York Toronto London.
Steel, R., & Torrie, J. H. (1960) · Cited by 4,633
The aggregation of blood platelets
Born, G. V. R., & Cross, M. J. (1963) · The Journal of Physiology · doi:10.1113/jphysiol.1963.sp007185 · Cited by 2,111
Drugs Which Inhibit Prostaglandin Biosynthesis
Flower, R. J. (1974) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06634-7 · Cited by 1,323
Nonparametric Statistical Methods
Gibbons, J. D. (1974) · Technometrics · doi:10.1080/00401706.1974.10489221 · Cited by 1,115
The separation of active and inactive forms of heparin
Lam, L. H., Silbert, J. E., & Rosenberg, R. D. (1976) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(76)90558-1 · Cited by 492
Self-citationActions and Interactions of Antithrombin and Heparin
Bleich, H. L., Boro, E. S., & Rosenberg, R. D. (1975) · New England Journal of Medicine · doi:10.1056/nejm197501162920307 · Cited by 459
Self-citationAndersson, L.-O., Barrowcliffe, T. W., Holmer, E., Johnson, E. A., & Sims, G. E. C. (1976) · Thrombosis Research · doi:10.1016/0049-3848(76)90105-5 · Cited by 457
Höök, M., Björk, I., Hopwood, J., & Lindahl, U. (1976) · FEBS Letters · doi:10.1016/0014-5793(76)80592-3 · Cited by 423
Gel Filtration: A New Technique for Separation of Blood Platelets from Plasma
Tangen, O., Berman, H. J., & Marfey, P. (1971) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1654301 · Cited by 309
Correlation between structure and function of heparin
Rosenberg, R. D., & Lam, L. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.3.1218 · Cited by 281
Self-citationThe molecular-weight-dependence of the anti-coagulant activity of heparin
Laurent, T. C., Tengblad, A., Thunberg, L., Höök, M., & Lindahl, U. (1978) · Biochemical Journal · doi:10.1042/bj1750691 · Cited by 273
Lapetina, E. G., Schmitges, C. J., Chandrabose, K. A., et al. (1977) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(77)91575-3 · Cited by 204
Heparin-lipoprotein lipase interactions.
Olivecrona, T., Bengtsson, G., Marklund, S., Lindahl, U., & Höök, M. (1977) · PubMed · Cited by 139
The Potentiation of Platelet Aggregation and Adhesion by Heparin in Vitro and in Vivo
Thomson, C. L., Forbes, C. D., & Prentice, C. R. M. (1973) · Clinical Science · doi:10.1042/cs0450485 · Cited by 134
Timmons, S., & Hawiger, J. (1978) · Thrombosis Research · doi:10.1016/0049-3848(78)90300-6 · Cited by 132
Structure-function relationships of heparin species
ROSENBERG, R. D., Armand, G., & Lam, L. H. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.7.3065 · Cited by 127
Self-citationStudies on the Mechanism of Ristocetin-Induced Platelet Agglutination
Coller, B. S., & Gralnick, H. R. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108778 · Cited by 86
Highly active heparin species with multiple binding sites for antithrombin
ROSENBERG, R. D., Jordan, R. E., Favreau, L. V., & Lam, L. H. (1979) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(79)90260-2 · Cited by 85
Self-citation[53] Antithrombin-heparin cofactor
Damus, P. S., & ROSENBERG, R. D. (1976) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(76)45056-5 · Cited by 70
Self-citationInhibition of Thrombin Induced Aggregation of Human Platelets by Heparin
Eika, C. (1971) · Scandinavian Journal of Haematology · doi:10.1111/j.1600-0609.1971.tb01976.x · Cited by 67
Anticoagulant and platelet aggregating activities of heparin
Eika, C. (1973) · Thrombosis Research · doi:10.1016/0049-3848(73)90045-5 · Cited by 26
Cited by
Weitz, J. I. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709043371007 · Cited by 1,533
Aspirin, Heparin, or Both to Treat Acute Unstable Angina
Théroux, P., Ouimet, H., McCans, J., Latour, J.-G., Joly, P., Lévy, G., Pelletier, E., Juneau, M., Stasiak, J., deGuise, P., et al. (1988) · New England Journal of Medicine · doi:10.1056/nejm198810273191701 · Cited by 1,276
Garcia, D. A., Baglin, T. P., Weitz, J. I., & Samama, M. M. (2012) · Chest · doi:10.1378/chest.11-2291 · Cited by 1,091
Heparin and Low-Molecular-Weight Heparin
Hirsh, J., Warkentin, T. E., Raschke, R., Granger, C., Ohman, E. M., & Dalen, J. E. (1998) · Chest · doi:10.1378/chest.114.5_supplement.489s · Cited by 1,031
Heparin and Low-Molecular-Weight Heparin
Hirsh, J., & Raschke, R. (2004) · Chest · doi:10.1378/chest.126.3_suppl.188s · Cited by 971
Metadata
- Authors
- Salzman, E. W., Rosenberg, R. D., Smith, M. H., Lindon, J. N., & Favreau, L.
- Venue
- Journal of Clinical Investigation
- Published
- 1980-01-01
- Volume
- 65
- Issue
- 1
- Pages
- 64-73
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2112799238
- Cited by
- 591
- References
- 24
- FWCI
- 18.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.